Navigation Links
Alexion to Present at the William Blair 28th Annual Growth Stock Conference

CHESHIRE, Conn., June 13 /PRNewswire-FirstCall/ -- Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that Vikas Sinha, Senior Vice President and Chief Financial Officer of Alexion Pharmaceuticals, will present at the William Blair 28th Annual Growth Stock Conference in Chicago at 9:10 a.m., local time (10:10 a.m., eastern) on Thursday, June 19, 2008.

An audio webcast of Mr. Sinha's remarks will be available live. You can access the webcast at: An archived version of the remarks will also be available through the Company's web site for a limited time following the conference.


SOURCE Alexion Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Notice of Time Change for Alexions Presentation at the Bank of America 2008 Health Care Conference
2. Alexion Reports First Quarter 2008 Results
3. Alexion Reports Fourth Quarter and Full Year 2007 Results
4. Alexion Acquires All Rights to OMRF Patents Related to Soliris(R)
5. Alexion Pharmaceuticals Invites You to Participate in its Fourth Quarter and Full Year 2007 Results Conference Call and Web Cast
6. Alexion to Present at Bear Stearns Healthcare Conference
7. Exelixis Announces June 19 Webcast of Presentation at the William Blair 28th Annual Growth Stock Conference
8. Genaera Corporation to Present at BIO Business Forum
9. Oncolytics Biotech Inc. to Present at BIO 2008 International Convention
10. Senesco Technologies to Present at BIO 2008 Business Forum
11. BioMS Medical to present at 2008 BIO International Convention
Post Your Comments:
(Date:10/12/2015)... Group, Inc. (NASDAQ: MDXG ), the leading regenerative ... to develop and market advanced products and therapies for ... and the Dental sectors of healthcare, announced today the ... Company has been dismissed by the court.  ... "As we suspected, this case was brought by an ...
(Date:10/12/2015)... cell surface marker detection market is expected ... new report by Grand View Research, Inc. This growth in ... diseases and other cell-associated disorders. --> cell surface ... billion by 2022, according to a new report by Grand ... to rise in incidence of oncology diseases and other cell-associated ...
(Date:10/12/2015)... DIEGO , Oct. 12, 2015  Patara ... debilitating allergic and inflammatory diseases and conditions, today ... A preferred stock financing. Concurrent with the close ... entered into a Loan and Security Agreement with ... up to $7 million. Patara will use the ...
(Date:10/12/2015)... Belgium , Oct. 12, 2015 ... results from a completed clinical study of its NuQ ® ... published in the online issue of Clinical Epigenetics , ... study was conducted in collaboration with Lund ... Roland Andersson , MD, PhD, Professor of Surgery and ...
Breaking Biology Technology:
(Date:9/30/2015)... BEACH GARDENS, Fla. , Sept. 30, 2015 /PRNewswire/ ... earlier this month issued another key ruling in favor ... (ITC,s) determination that Korean fingerprint scanner company Suprema and ... Tariff Act of 1930, a trade provision that declares ... with import trade, by infringing two of Crossmatch,s patents, ...
(Date:9/28/2015)... , Sept. 28, 2015  The monitoring of ... and body temperature, is an essential component of ... indicators of deterioration in a patient,s condition. However, ... signs are typically taken during routine observation rounds ... a patient deteriorates between these observation rounds, the ...
(Date:9/24/2015)...  EyeLock LLC, a market leader of iris-based identity ... latest technology in Booth #602 at next week,s ASIS ... EyeLock,s iris authentication technology provides an unprecedented level ... it the most proven way to authenticate one,s identity ... deliver a fast and friendly user experience to identify ...
Breaking Biology News(10 mins):